Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 455

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 455
---
 Co., Ltd., a South Korean neuro -interventionmedical device distributor. OSR Holdings issued 70,847shares of OSR Holdings’ common stock to the sole shareholder of RMC, Mr. Chan Kyu Park, the founder and CEO of RMC, and also a minority shareholder of OSR Holdings. On March 31, 2023, OSR Holdings acquired all of the outstanding shares of Darnatein, an Incheon, South Korea -basedcorporation that is developing therapies for age -relatedand degenerative diseases and their associated chronic disorders and complications. OSR Holdings issued to the stockholders of Darnatein 590,425shares of OSR Holdings’ common stock. On a consolidated basis, OSR Holdings has funded its operations primarily through the issuance of common shares, convertible preferred shares, convertible bonds and loans. As of June 30, 2024, on a consolidated basis, OSR Holdings has raised a cumulative KRW 11.64 billion in gross proceeds through the issuance of common shares, convertible preferred shares and debt (including bank loans of KRW 443.25 million made to RMC). In addition, during 2024, OSR executed (a) loan agreements permitting it to borrow an aggregate of $1.1 million from its affiliate BCME consisting of the following individual loans: (1) $50,000 due February 21, 2025 (repaid in 2024) bearing annual interest of 5.5%; (2) $300,000 (of which only $250,000 was borrowed) due November 7, 2025 bearing interest of 3.0%; and (3) $750,000 due March 24, 2025 ($2000 of which was repaid in 2024) bearing interest of 3.0%; and (b) a promissory note by which OSR Holdings borrowed $300,000 from BLAC due October 25, 2025 bearing interest of 3.96%. Each of the loans is unsecured and were for working capital purposes, including providing working capital to subsidiaries. OSR Holdings has incurred net losses each year since inception except for 2022 when OSR Holdings recorded a net profit of KRW 1.3 billion due to a one -timegain (non -cash) on the exchange of the 1,750 BCME preference shares for shares of Vaximm. OSR Holdings’ net loss in 2021 was